StonvexLoading…
StonvexStonvexStonvexCore line items from CARL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $16.12M | $50.51M | $35.35M | $22.27M |
Operating Income | $-9.28M | $-30.57M | $-21.26M | $-12.22M |
Net Income | $-8.70M | $-29.63M | $-21.02M | $-6.77M |
EPS (Diluted) | $-0.32 | $-2.12 | $-2.15 | $-2.94 |
Total Assets | $118.77M | $130.12M | $134.86M | $53.27M |
Total Liabilities | $26.52M | $31.25M | $28.20M | $27.61M |
Cash & Equivalents | $73.02M | $85.79M | $115.37M | $33.47M |
Free Cash Flow OCF − CapEx | $-13.09M | $-29.62M | $-24.23M | $-15.61M |
Shares Outstanding | 27.18M | 26.60M | 26.58M | 4.60M |